182 related articles for article (PubMed ID: 20157706)
1. 68Ga-labelled recombinant antibody variants for immuno-PET imaging of solid tumours.
Eder M; Knackmuss S; Le Gall F; Reusch U; Rybin V; Little M; Haberkorn U; Mier W; Eisenhut M
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1397-407. PubMed ID: 20157706
[TBL] [Abstract][Full Text] [Related]
2. Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.
Eder M; Wängler B; Knackmuss S; LeGall F; Little M; Haberkorn U; Mier W; Eisenhut M
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1878-86. PubMed ID: 18509635
[TBL] [Abstract][Full Text] [Related]
3. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
[TBL] [Abstract][Full Text] [Related]
4. Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.
Vosjan MJ; Perk LR; Roovers RC; Visser GW; Stigter-van Walsum M; van Bergen En Henegouwen PM; van Dongen GA
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):753-63. PubMed ID: 21210114
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.
Eder M; Schäfer M; Bauder-Wüst U; Hull WE; Wängler C; Mier W; Haberkorn U; Eisenhut M
Bioconjug Chem; 2012 Apr; 23(4):688-97. PubMed ID: 22369515
[TBL] [Abstract][Full Text] [Related]
6. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Eder M; Krivoshein AV; Backer M; Backer JM; Haberkorn U; Eisenhut M
Nucl Med Biol; 2010 May; 37(4):405-12. PubMed ID: 20447550
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and evaluation of
Liolios C; Shegani A; Roupa I; Kiritsis C; Makarem A; Paravatou-Petsotas M; Pelecanou M; Bouziotis P; Papadopoulos M; Kopka K; Pirmettis I
Bioorg Chem; 2020 Jul; 100():103855. PubMed ID: 32428743
[TBL] [Abstract][Full Text] [Related]
8. Engineered antibody fragments with infinite affinity as reporter genes for PET imaging.
Wei LH; Olafsen T; Radu C; Hildebrandt IJ; McCoy MR; Phelps ME; Meares C; Wu AM; Czernin J; Weber WA
J Nucl Med; 2008 Nov; 49(11):1828-35. PubMed ID: 18927335
[TBL] [Abstract][Full Text] [Related]
9. A multivalent recombinant antibody fragment specific for carcinoembryonic antigen.
Perez L; Ayala M; Pimentel G; Bell H; Canaán-Haden L; Bequet M; González LJ; Miranda M; Ravelo R; Roque L; Acevedo B; Oliva JP; Gavilondo JV
Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):39-48. PubMed ID: 16101587
[TBL] [Abstract][Full Text] [Related]
10. Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.
Perk LR; Stigter-van Walsum M; Visser GW; Kloet RW; Vosjan MJ; Leemans CR; Giaccone G; Albano R; Comoglio PM; van Dongen GA
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1857-67. PubMed ID: 18491091
[TBL] [Abstract][Full Text] [Related]
11. Monomeric and Dimeric
Liolios C; Buchmuller B; Bauder-Wüst U; Schäfer M; Leotta K; Haberkorn U; Eder M; Kopka K
J Med Chem; 2018 Mar; 61(5):2062-2074. PubMed ID: 29432691
[TBL] [Abstract][Full Text] [Related]
12. Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a
Nawaz S; Mullen GED; Sunassee K; Bordoloi J; Blower PJ; Ballinger JR
EJNMMI Res; 2017 Oct; 7(1):86. PubMed ID: 29067565
[TBL] [Abstract][Full Text] [Related]
13. [
Shi S; Zhang L; Wu Z; Zhang A; Hong H; Choi SR; Zhu L; Kung HF
Nucl Med Biol; 2020; 82-83():17-24. PubMed ID: 31869735
[TBL] [Abstract][Full Text] [Related]
14. In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Schneider DW; Heitner T; Alicke B; Light DR; McLean K; Satozawa N; Parry G; Yoo J; Lewis JS; Parry R
J Nucl Med; 2009 Mar; 50(3):435-43. PubMed ID: 19223400
[TBL] [Abstract][Full Text] [Related]
15. A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue.
Tolmachev V; Velikyan I; Sandström M; Orlova A
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1356-67. PubMed ID: 20130858
[TBL] [Abstract][Full Text] [Related]
16. A New [
Zha Z; Wu Z; Choi SR; Ploessl K; Smith M; Alexoff D; Zhu L; Kung HF
Mol Pharm; 2020 May; 17(5):1674-1684. PubMed ID: 32251600
[TBL] [Abstract][Full Text] [Related]
17. Comparative preclinical evaluation of
Trencsényi G; Dénes N; Nagy G; Kis A; Vida A; Farkas F; Szabó JP; Kovács T; Berényi E; Garai I; Bai P; Hunyadi J; Kertész I
J Pharm Biomed Anal; 2017 May; 139():54-64. PubMed ID: 28273651
[TBL] [Abstract][Full Text] [Related]
18. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
[TBL] [Abstract][Full Text] [Related]
19. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
Nielsen UB; Adams GP; Weiner LM; Marks JD
Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
